| Angelia Woodward, MD | |
|
809 University Blvd E, Tuscaloosa, AL 35401-2029 | |
| (205) 759-7111 | |
| Not Available |
| Full Name | Angelia Woodward |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 809 University Blvd E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962592774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 17301 (Alabama) | Primary |
| Entity Name | Dch Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841394418 PECOS PAC ID: 8123924248 Enrollment ID: O20040204000874 |
News Archive
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. Understanding and being able to control these alterations could lead to new approaches for activating or inactivating genes linked to cancer.
GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.
Exposure in the womb to chemicals like Bisphenol-A (BPA) and Diethylstilbestrol (DES) can increase an offspring's risk of breast cancer, researchers at Yale School of Medicine report in a study published in current issue of Hormones and Cancer, a journal of The Endocrine Society.
KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.
› Verified 1 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20050218000756 |
News Archive
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. Understanding and being able to control these alterations could lead to new approaches for activating or inactivating genes linked to cancer.
GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.
Exposure in the womb to chemicals like Bisphenol-A (BPA) and Diethylstilbestrol (DES) can increase an offspring's risk of breast cancer, researchers at Yale School of Medicine report in a study published in current issue of Hormones and Cancer, a journal of The Endocrine Society.
KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.
› Verified 1 days ago
| Entity Name | Relias Emergency Medicine Specialists Of Northport, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699261149 PECOS PAC ID: 2668724634 Enrollment ID: O20181003001104 |
News Archive
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. Understanding and being able to control these alterations could lead to new approaches for activating or inactivating genes linked to cancer.
GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.
Exposure in the womb to chemicals like Bisphenol-A (BPA) and Diethylstilbestrol (DES) can increase an offspring's risk of breast cancer, researchers at Yale School of Medicine report in a study published in current issue of Hormones and Cancer, a journal of The Endocrine Society.
KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.
› Verified 1 days ago
| Entity Name | Relias Emergency Medicine Specialists Of Regional, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619463163 PECOS PAC ID: 9436401106 Enrollment ID: O20181008000902 |
News Archive
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. Understanding and being able to control these alterations could lead to new approaches for activating or inactivating genes linked to cancer.
GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.
Exposure in the womb to chemicals like Bisphenol-A (BPA) and Diethylstilbestrol (DES) can increase an offspring's risk of breast cancer, researchers at Yale School of Medicine report in a study published in current issue of Hormones and Cancer, a journal of The Endocrine Society.
KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angelia Woodward, MD Po Box 2153, Dept. 5078, Birmingham, AL 35287-0002 Ph: (205) 759-7111 | Angelia Woodward, MD 809 University Blvd E, Tuscaloosa, AL 35401-2029 Ph: (205) 759-7111 |
News Archive
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. Understanding and being able to control these alterations could lead to new approaches for activating or inactivating genes linked to cancer.
GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.
Exposure in the womb to chemicals like Bisphenol-A (BPA) and Diethylstilbestrol (DES) can increase an offspring's risk of breast cancer, researchers at Yale School of Medicine report in a study published in current issue of Hormones and Cancer, a journal of The Endocrine Society.
KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.
› Verified 1 days ago
Nicholas Machael Vetrano, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7122 | |
Dr. Alan Heins, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 5th Ave E, Tuscaloosa, AL 35401 Phone: 205-348-6262 Fax: 205-348-6262 | |
Nicholas Charles Ruth, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Peter Bryce Blvd, Tuscaloosa, AL 35401 Phone: 205-348-1770 Fax: 205-348-1772 | |
Dr. Phillip Kelley Bobo, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 32 15th St, Tuscaloosa, AL 35401 Phone: 205-345-2326 Fax: 205-345-0708 | |
Christopher Earl Mcgee, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5005 Oscar Baxter Dr, Tuscaloosa, AL 35405 Phone: 205-343-2225 | |
Dr. Jf Donal Conway, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7122 | |
Jeremey Lindley, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 |